作者
Stefan D. Anker,Javed Butler,Gerasimos Filippatos,João Pedro Ferreira,Edimar Alcides Bocchi,Michael Böhm,Hans‐Peter Brunner‐La Rocca,Dong‐Ju Choi,Vijay Chopra,Eduardo Chuquiure‐Valenzuela,Nadia Giannetti,Juan Esteban Gómez‐Mesa,Stefan Janssens,James L. Januzzi,José Ramón González‐Juanatey,Béla Merkely,Stephen J. Nicholls,Sergio V. Perrone,Ileana L. Piña,Piotr Ponikowski,Michele Senni,David Sim,Jindřich Špinar,Iain Squire,Stefano Taddei,Hiroyuki Tsutsui,Subodh Verma,Dragoş Vinereanu,Jian Zhang,Peter E. Carson,Carolyn S.P. Lam,Nikolaus Marx,Cordula Zeller,Naveed Sattar,Waheed Jamal,Sven Schnaidt,Janet Schnee,Martina Brueckmann,Stuart J. Pocock,Faı̈ez Zannad,Milton Packer
摘要
Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.